PCSK9 and obesity disorder: We conclude that PCSK9 may be a useful biomarker of lipoprotein metabolism in fetal life because PCSK9 levels in the neonatal-placental circulation are susceptible to several conditions that affect lipoprotein regulation including maternal overweight status/obesity.